Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Become a Member | Sign in
Home>News>This Article

Advanced Clinical Announces New Executive Vice President

Published: Monday, April 22, 2013
Last Updated: Monday, April 22, 2013
Bookmark and Share
Julie A. Ross appointed as Executive Vice President, CRO Operations.

Advanced Clinical has announced an addition to its leadership team: Julie A. Ross, has been hired as Executive Vice President, CRO Operations.

Julie Ross is a tenured executive leader who has been instrumental in the development and the success of multiple clinical operations divisions.

Previously with inVentiv Health Clinical (formerly Pharmanet/i3), Ms. Ross served as Senior Vice President, Global Strategic Services and had oversight of Feasibility, Patient Recruitment and Retention, Global Study Start-up, Document Management and Publishing, Expedited Safety Reporting, Grants and Contracts, Clinical Trial Supply Management and Medical Writing.

Prior to her role at inVentiv, Ms. Ross led Essential Group, a full-service CRO and patient recruitment company, which she helped build and position for its acquisition by inVentiv Health.

“We are very excited to welcome Julie to the Advanced Clinical team,” said Leo Sheridan, CEO of Advanced Clinical. “We are honored to bring Julie’s caliber and experience to our team as we continue expanding our CRO solutions. Her diverse knowledge and expertise in clinical research, as well as her strong leadership skills, are a perfect fit for Advanced Clinical.”

A graduate of the University of Wisconsin, La Crosse with a bachelor's degree in Nuclear Medicine Technology, Ms. Ross has been in the clinical research industry for over twenty five years.

She has authored many clinical research articles and is a well-known industry speaker. Ms. Ross will be based out of Advanced Clinical’s headquarters in Deerfield, IL.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Lucentis Effective for Proliferative Diabetic Retinopathy
NIH-funded clinical trial marks first major advance in therapy in 40 years.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Gene Therapy Staves Off Blindness from Retinitis Pigmentosa in Canine Model
NIH-funded study suggests therapeutic window may extend to later-stage disease.
Treatment for Rare Bleeding Disorder is Effective
Researchers in Manchester have demonstrated for the first time the relative safety and effectiveness of treatment, eltrombopag, in children with persistent or chronic immune thrombocytopenia (ITP), as part of an international duo of studies.
HIV Vaccine Human Trials Begin
Baltimore-based Institute has begun enrolling volunteers for initial phase 1 clinical trials.
New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
A phase three clinical trial of a new enzyme replacement medication, sebelipase alfa, showed a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency, an inherited enzyme deficiency that can result in scarring of the liver and high cholesterol.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos